Hsp90 inhibitors and drug resistance in cancer: The potential benefits of combination therapies of Hsp90 inhibitors and other anti-cancer drugs

Xiangyi Lu(Wayne State University), Douglas M. Ruden(Wayne State University), Luan Wang(Wayne State University), Li Xiao(Stanford University)
Biochemical Pharmacology
November 22, 2011
Cited by 114


Related Papers